Trials / Completed
CompletedNCT04525222
mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation
An mHealth Mood Management Tool to Improve Population-Level Cessation
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 242 (actual)
- Sponsor
- Fred Hutchinson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This phase I trial investigates a new smartphone application (called Actify) for improving population-level smoking cessation and mood management. Actify delivers behavioral activation therapy for depression as part of a smoking cessation intervention and will be compared to another smoking cessation smartphone application that is based on current clinical practice guidelines. Participants will be randomly assigned to receive one of two smartphone applications and accompanying text notifications to help with quitting smoking and improved mood.
Detailed description
OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use Actify app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications. ARM II: Participants use United States (US) Clinical Practice Guidelines (USCPG) app for smoking cessation for 8 weeks. Participants also receive motivational messages and smoking cessation information via text notifications. After completion of study, participants are followed up at 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Health Promotion and Education | Receive motivational messages and smoking cessation information via text notifications |
| BEHAVIORAL | Smoking Cessation Intervention (Actify app) | Use Actify app |
| BEHAVIORAL | Smoking Cessation Intervention (Current Standard Care app) | Use (USCPG) Current Standard Care app |
| OTHER | Survey Administration | Ancillary studies |
Timeline
- Start date
- 2022-05-09
- Primary completion
- 2022-12-19
- Completion
- 2023-04-12
- First posted
- 2020-08-25
- Last updated
- 2024-03-07
- Results posted
- 2024-03-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04525222. Inclusion in this directory is not an endorsement.